Your essential daily briefing on the business, policy, and politics of cannabis — in just 5 minutes.
Premium
Nov 12, 2026
•
3 min read
Organigram CEO James Yamanaka says in an exclusive interview that Aurora’s European medical business will drive growth, even as Curaleaf argues the C$7.80 deal is a bad one for Organigram shareholders.
DEA turns away medical businesses in six states
Nov 11, 2026
4 min read
Texas legislators file reform bills
2 min read
The state’s new rules expand medical access, cut security costs and loosen restrictions for cannabis retailers.
Nov 10, 2026
Ryan Dominguez returns after Question 8’s defeat in Massachusetts
Nov 9, 2026
Counting down to Cultivated in Las Vegas